Categoría: Stem Cells
-
Clinical Results From Embryonic Stem Cells are «Decades Away»
A review of recent, and not-so-recent, advances in stem cell science reveal that any clinical applications of embryonic stem cell research are still decades away.
-
Wisconsin Stem Cell Company Announces Licensing Agreement
As expected, Cellular Dynamics International announces yet another licensing agreement for iPS cell technology.
-
Adult Stem Cells Continue Going to the Dogs
Once again, the adult stem cell therapy pioneered by the veterinary company Vet-Stem comes to the rescue of man’s best friend.
-
Veterinary Stem Cell Therapies Translate into Human Therapies
Autologous adult stem cell therapies that are routinely used for the treatment of injuries and degenerative conditions in dogs and horses are now being translated into human clinical trials.
-
New NIH Stem Cell Guidelines are Slowing Research
The new Guidelines issued by NIH are seen by many embryonic stem cell scientists as an obstacle to research.
-
BioTime Receives Second Round of Funding
The embryonic stem cell company BioTime receives $4 million in its second equity tranche.
-
NIH received varied responses, some poignant, on stem-cell draft
There were approximately 49,000 comments sent into the NIH in response to a publicly available draft of the new guidelines to embryonic stem cell research.
-
New Technology Breakthroughs Showcased at Annual Stem Cell Conference
New advances in instrumentation and laboratory technology are featured at this year’s ISSCR conference in Barcelona.
-
BioTime Announces Agreement With Millipore
BioTime’s subsidiary, Embryome Sciences, enters into a co-marketing agreement with Millipore.
-
Boston’s biotech community leads wave of stem cell consolidation, deal making
Merger of IZumi Bio and Pierian Inc was announced, with the new company being named IPierian.